key: cord-0998538-5wu26zmz
authors: Scullen, Tyler; Mathkour, Mansour; Keen, Joseph R.
title: Editorial, Authors Reply: Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community.
date: 2020-06-23
journal: World Neurosurg
DOI: 10.1016/j.wneu.2020.06.115
sha: abb686f6a2ca8a0e86a3803c566c030f16487f47
doc_id: 998538
cord_uid: 5wu26zmz

nan

We thank Mishra et al. for their comments regarding our manuscript, who discuss the multifactorial nature 1-4 of severe coronavirus disease 2019 (COVID-19) secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and raise several comments regarding to pathogenesis of injury in patients with central nervous system (CNS) involvement. The authors note that severe disease has been observed to be associated with an uncontrolled immune response exacerbating injury as evident with reported elevations in a wide range of acute phase reactants (APR) 4 , a characteristic relatively atypical for viral disease 1,5 They then remark that a temporal association between CNS injury and APR trends has not been shown 6, 7 . We agree that this is an interesting area of future study given but caution that difficulties may arise in that systemic markers may not necessarily correlate with neuroinflammation 5 , may be confounded by systemic severe disease 5 , and that COVID-19 associated encephalopathy may at times be of a non-inflammatory etiology 8,9 . D-dimer elevations, an APR associated with hypercoagulability, are later discussed by Mishra to be a pathway of ischemic CNS injury without direct viral involvement. As the commenters mention, D-dimer elevations have been documented to be correlated with severe COVID-19 and multiple associated thrombotic complications including ischemic stroke 4,6 . Ischemic insult in such patients is presumed to be secondary to intracranial large vessel occlusion (LVO) as has been shown in viral associated pulmonary embolism and deep venous thrombosis 8 , however multiple reports, including one recently conducted analyzing neurological manifestations in critical COVID-19 at our own facility in New Orleans, Lousiana, have shown a high proportion of large territory anterior circulation infarcts with no evidence of LVO and presence of segmental non-occlusive stenosis 8, 9 . These findings suggest an alternative pathway of direct viral associated vasculopathy, as has been observed and reported in Human Immunodeficiency Virus 1 and 2 as well as Human Herpes Virus 3 infections 9 . Reported cases of COVID-19 associated vasculopathy and secondary acute ischemic stroke are often in the context of therapeutic anticoagulation, making thrombosis less likely 9 . While an interesting topic of active discussion concerning COVID-19 associated cerebrovascular disease, coagulopathy would not account for other CNS manifestations, including electrographic and radiographic encephalopathy [9] [10] [11] . Interestingly, Mishra also raises the possibility of hypoxia cause of CNS damage. Hypoxic injury, among with many other consequences of severe multisystem disease, may very well be a contributor to CNS involvement, and imaging characteristic of hypoxic-anoxic injury have been reported 9 . We postulate that both mechanisms of hypoxia and coagulopathy are one of several pathways of indirect and direct CNS injury secondary to SARS-CoV-2 infection.

Mishra and colleague next remark that there have been no pathology reports from autopsy studies confirming the presence of SARS-CoV-2 in the CNS. We agree that neuropathology by way of brain cutting and relevant stains would be of vital interest in further disease characterization. This observation likely stems from the fact the SARS-CoV-2 is regarded by pathologists as a hazardous organism, and autopsies are conducted in a conservative manner to limit exposure 12, 13 . Despite this, accumulating literature documenting neurologic involvement in COVID-19 9-11 has fueled a growing interest in neuropathological research of post-mortem tissue 14 . As we discuss, SARS-CoV-2 genetic material has been isolated from cerebrospinal fluid, even in cases where oropharyngeal swab testing is negative 15 .

Mishra et al. mention that the comorbidities appear to be associated with severe COVID-19 and with cerebrovascular accidents associated with severe disease. We very much agree that evolving evidence concerning strongly links critically hospitalized patients with confirmed COVID-19 links co-morbidities of diabetes mellitus type 2, hypertension, chronic obstructive pulmonary disease, chronic kidney disease, obesity, and cardiovascular disease with an increased risk of more severe disease course and multi-system effects 16.17 . Presumably, increasing age predicts medical co-morbidity, the majority of which mentioned result in increased strain on the cardiopulmonary system. Therefore it is intuitive that patients with multisystemic disease at baseline are more likely to have a more severe clinical course in the event of infectious insult, particularly if their immune system or innate inflammatory cascade is in anyway deregulated.

Concerning the final comments on the prevalence of cerebrovascular disease in the context of multi-system involvement and severe COVID-19, as above mentioned, the increased prevalence of acute cerebrovascular disease in patients with severe infection is thought to be related to elevated D-dimer levels, which have been previously shown to correlate with unfavorable outcomes in stroke patients 9,18 , although not always as a result of LVO 9 . It is likely that thrombosis secondary to severe infection and a hypercoagulable state represents a subset of patients with neurological involvement, but for those who are therapeutically anticoagulated at the time of clinical deterioration, D-dimer elevations are suspected to be correlative and not causative. Cerebrovascular disease is a known predisposing factor for the development of acute respiratory distress syndrome in a neurocritical care setting 18 . It is therefore challenging to interpret what may be a confounding variable in a novel disease with a heterogeneous clinical presentation likely consequent of multiple parallel and synergistic pathways. Recent reports have attempted to clarify specific disease patterns of CNS injury 9 and we agree the further study is necessary. While there are no specific guidelines concerning preexisting stroke or elevated D-dimer in the setting of COVID-19, it is easy to speculate that these patients likely have an increased likelihood of progressing to severe disease and warrant increased vigilance in monitoring disease course.

Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases

Patterns of heart Injury in COVID -19 and relation to outcome

Neurologic Features in Severe SARS-CoV-2 Infection

Thrombosis risk associated with COVID-19 infection. A scoping review

COVID-19 associated encephalopathies and cerebrovascular disease: the New Orleans experience

COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia

Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology

Autopsy in suspected COVID-19 cases

SARS-CoV-2 Pandemic: Review of the Literature and Proposal for Safe Autopsy Practice

The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries

Understanding pathways to death in patients with COVID-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease